Michael F. Burgess - Jun 1, 2021 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Role
Head of Research & Development
Signature
/s/ Francis I. Perier, Jr., Attorney-in-fact
Stock symbol
SWTX
Transactions as of
Jun 1, 2021
Transactions value $
$0
Form type
4
Date filed
6/1/2021, 05:25 PM
Previous filing
May 10, 2021
Next filing
Jun 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWTX Common Stock Award $0 +27.5K $0.00 27.5K Jun 1, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SWTX Stock Option (Right to Buy) Award $0 +225K $0.00 225K Jun 1, 2021 Common Stock 225K $81.68 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock awards. The restricted stock awards shall vest as follows: thirty three percent (33%) to vest on June 1, 2022, another thirty three percent (33%) to vest on June 1, 2023 and the remaining thirty four percent (34%) to vest on June 1, 2024, such that the restricted stock awards are fully vested on June 1, 2024, subject to continued service to the Company by the Reporting Person.
F2 This option shall vest as follows: twenty five percent (25%) on June 1, 2022, and thereafter in thirty six (36) equal monthly installments until fully vested, subject to continued service to the Company by the Reporting Person.